As Home IVs Grow, Medicare Patients Miss Out - WSJ.com:
"Growing numbers of patients needing intravenous medications are getting their treatments at home. But a gap in Medicare coverage is making it harder for older and sicker patients to swap hospital stays for home care.
Hundreds of new intravenous drugs and biologic products have come on the market in recent years to treat maladies such as infections, cancer and chronic diseases. Administering these medications at home generally costs $150 to $200 a day, far below the $1,500-to-$2,500-a-day cost of a typical inpatient hospital stay. Home-infusion therapy also eliminates the risk that patients will be exposed to infections caused by hospital bacteria that can invade through IV lines and catheters."
'via Blog this'
Return Home: The Designated Representative and Exemptee Blog
CA HMDR Exemptee online internet-based training certification by SkillsPlus Intl Inc - Enhanced for iPad
The Exemptee Institute
CA Designated Representative online web-based training certification by SkillsPlus Intl Inc - Available around-the-clock 24 x 7 - Available for iPad
FL Designated Representative online e-Learning exam preparation by SkillsPlus Intl Inc.
The Designated Representative Institute
SkillsPlus Intl Info Blog
Reimbursement Cuts to NY Medicaid Incontinence Supplies
27 minutes ago